About Noveome Biotherapy
Noveome Biotherapeutics develops ST266 a novel biologic derived from amnion-derived multicellular cytokine solution for wound healing and regenerative medicine applications
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Noveome Biotherapy. Response typically within 48 hours.
Company Info
TypeManufacturer
Founded2013
Employees100
Revenue$15M
HQPittsburgh, USA
